AI-driven solutions and strategic alliances
showcase Medtronic's promise to enhance the efficiency and
effectiveness of endoscopy
DUBLIN, April 10,
2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT),
a global leader in healthcare technology, announced the latest
advancements in artificial intelligence (AI) for endoscopic care by
unveiling ColonPRO™, the latest generation software for the GI
Genius™ intelligent endoscopy system, along with a strategic
collaboration designed to enhance patient care.
GI Genius™ was the first commercially available computer-aided
detection (CADe) system used AI to identify colorectal polyps. Its
significant impact has been well researched with more than 30
academic and real-world publications across a combined total of
23,000+ patients.1 Based on the current global install
base, the GI Genius™ system has the potential to impact 2.7 million
patients annually.2 Now, with the launch of ColonPRO™
software, the GI Genius™ system takes a significant leap forward in
AI-driven polyp detection by introducing an enhanced algorithm,
supported by a dataset that is double the size of the previous one,
resulting in a notable improvement in its detection capabilities.
Specifically, there's been a 9% reduction in false
positives.3 Additionally, the system now incorporates a
new feature that provides procedural
highlights;3 an important milestone in its ability
to automate physicians' workflow, reduce administrative burdens in
documentation, and pave the way for future integration with
electronic health records. The update also provides user interface
enhancements to support the development of third-party applications
through the AI Access™ platform, introduced at last year's Genius
Summit.
Medtronic also announced its collaboration with Modernizing
Medicine® (ModMed), a pioneer in healthcare technology and
Electronic Health Records (EHR), further emphasizing its commitment
to a synergistic approach to the future of endoscopic care.
ModMed's gGastro® EHR software is complementary to the GI Genius™
system, offering robust documentation solutions.
"Through our collaboration with ModMed, we can continue to help
gastroenterologists achieve greater efficiency by streamlining
workflows and leveraging augmented decision-making, freeing up
valuable time for patient care," said Raj Thomas, president of the
Endoscopy business, which is part of the Medical Surgical Portfolio
at Medtronic. "We are committed to working with industry leaders
and focusing on where we can best offer innovation, addressing
unmet clinical needs and elevating the standard of
care."
The companies will begin testing out new capabilities for future
integration, moving closer to their shared vision of enabling
gGastro® EHR software to receive real-time, AI-generated data from
the GI Genius™ system, making the documentation process more
efficient and enabling physicians to spend more of their time on
patient care.
"This is a true game changer for physicians — it represents
precisely how physicians want AI technologies implemented and it
will allow us to focus our energy on thinking about the patient and
providing the best care possible," said Dr. Jason Sugar, Gastroenterology Team Lead at
ModMed.
Medtronic's announcements at the Genius Summit underscore its
dedication to advancing colorectal cancer care with AI innovations
and strategic collaborations. Medtronic remains at the forefront of
delivering solutions that address the needs of patients and
physicians alike.
About Medtronic
Bold thinking. Bolder actions. We are
Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global
healthcare technology company that boldly attacks the most
challenging health problems facing humanity by searching out and
finding solutions. Our Mission — to alleviate pain, restore health,
and extend life — unites a global team of 95,000+ passionate people
across 150 countries. Our technologies and therapies treat 70
health conditions and include cardiac devices, surgical robotics,
insulin pumps, surgical tools, patient monitoring systems, and
more. Powered by our diverse knowledge, insatiable curiosity, and
desire to help all those who need it, we deliver innovative
technologies that transform the lives of two people every second,
every hour, every day. Expect more from us as we empower
insight-driven care, experiences that put people first, and better
outcomes for our world. In everything we do, we are engineering the
extraordinary. For more information on Medtronic (NYSE:MDT), visit
www.Medtronic.com and follow Medtronic on LinkedIn.
About ModMed
At ModMed, we empower medical
practices to grow and scale by delivering better patient
experiences with cloud, data, and AI technologies. Leveraging
extensive clinical outcomes data, we design intelligent software
solutions that simplify, automate and streamline clinical workflows
and drive practice efficiency. With our specialty-specific EHRs,
practice management, revenue cycle management and analytics
solutions as well as products for patient engagement, payment
processing and marketing, we are trusted by over 35,000 providers
to drive clinical and operational success. Learn more at
modmed.com or our blog and connect via Facebook, LinkedIn,
Twitter and Instagram.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
Modernizing Medicine®, ModMed® and gGastro® are registered
trademarks of ModMed.
References
- Cosmo intelligent medical devices. The revolutionary GI Genius™
intelligent endoscopy module.
https://cosmoimd.com/gi-genius/ Accessed March 25, 2024
- Internal data, based on shared colonoscopy volumes per
facility
- CB1708-MN-US: GI Genius™ systems User Manual
Contacts:
|
|
Sabrina Zimring
|
Ryan
Weispfenning
|
Public Relations
|
Investor
Relations
|
+1-720-774-3454
|
+1-763-505-4626
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medtronic-unveils-the-future-of-ai-in-gi-genius-summit-2024-reveals-innovations-and-collaborations-that-advance-endoscopic-care-302113083.html
SOURCE Medtronic plc